Source: Benzinga

TG Therapeutics: TG Therapeutics to Participate in the Evercore HealthCONx Conference

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the 7th Annual Evercore HealthCONx Conference, being held at the Loews Coral Gables Hotel, in Florida on December 3-5, 2024. The fireside chat is scheduled to take place on Tuesday, December 3, at 10:00 AM ET.A live webcast of the fireside chat will be available on the Events page, located within ...Full story available on Benzinga.com

Read full article »
Annual Revenue
$100-500M
Employees
250-500
Michael S. Weiss's photo - Chairman & CEO of TG Therapeutics

Chairman & CEO

Michael S. Weiss

CEO Approval Rating

89/100

Read more